Rewiring innate and adaptive immunity with TLR9 agonist to treat osteosarcoma

被引：0
|
作者：
Caterina Cascini
Chiara Ratti
Laura Botti
Beatrice Parma
Valeria Cancila
Adriana Salvaggio
Cristina Meazza
Claudio Tripodo
Mario P. Colombo
Claudia Chiodoni
机构：
[1] Fondazione IRCCS Istituto Nazionale Dei Tumori,Department of Experimental Oncology, Molecular Immunology Unit
[2] University of Palermo School of Medicine,Department of Health Science, Tumor Immunology Unit
[3] Fondazione IRCCS Istituto Nazionale Dei Tumori,Pediatric Oncology
[4] IFOM,undefined
[5] FIRC Institute of Molecular Oncology,undefined
来源：
Journal of Experimental & Clinical Cancer Research | / 42卷
关键词：
Osteosarcoma; Immunomodulation; Lymphocyte activation; Macrophages; TLR9; Mouse models;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Lipid Nanoparticle Delivery Alters the Adjuvanticity of the TLR9 Agonist CpG by Innate Immune Activation in Lymphoid Tissue
    Zhong, Zifu
    Chen, Yong
    Deswarte, Kim
    Lauwers, Heleen
    De Lombaerde, Emily
    Cui, Xiaole
    Van Herck, Simon
    Ye, Tingting
    Gontsarik, Mark
    Lienenklaus, Stefan
    Sanders, Niek N.
    Lambrecht, Bart N.
    De Koker, Stefaan
    De Geest, Bruno G.
    ADVANCED HEALTHCARE MATERIALS, 2023, 12 (32)
  • [22] Development of an inhaled TLR9 agonist for the immunotherapy of lung cancer
    Gallotta, Marilena
    Assi, Hikmat
    Coffman, Robert L.
    Guiducci, Cristiana
    CANCER RESEARCH, 2017, 77
  • [23] Tolamba™ -: TLR9 receptor agonist treatment of allergic rhinitis
    Wang, Y.
    DRUGS OF THE FUTURE, 2007, 32 (06) : 497 - 500
  • [24] TLR9 Agonist Regulates Angiogenesis and Inhibits Corneal Neovascularization
    Wu, Jiahui
    Cui, Hongping
    Dick, Andrew D.
    Liu, Lei
    AMERICAN JOURNAL OF PATHOLOGY, 2014, 184 (06): : 1900 - 1910
  • [25] A novel TLR9 agonist as experimental therapy for prostate cancer
    Rayburn, E. R.
    Wang, H.
    Zhang, R.
    CHEMICO-BIOLOGICAL INTERACTIONS, 2006, 161 (03) : 211 - 212
  • [26] The TLR9 agonist CpG ODN attenuates cardiac hypertrophy
    Yang, L.
    Jiao, J.
    Zhang, J.
    Li, J.
    Tang, X.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (06) : 1011 - 1011
  • [27] TLR9 agonist regulates angiogenesis and inhibits corneal neovascularisation
    Wu, Jiahui
    Cui, Hongping
    Dick, Andrew D.
    Liu, Lei
    ANGIOGENESIS, 2014, 17 (03) : 744 - 744
  • [28] TLR9 is required for protective innate immunity in gram-negative bacterial pneumonia: Role of dendritic cells
    Bhan, Urvashi
    Lukacs, Nicholas W.
    Osterholzer, John J.
    Newstead, Michael W.
    Zeng, Xianying
    Moore, Thomas A.
    McMillan, Tracy R.
    Krieg, Arthur M.
    Akira, Shizuo
    Standiford, Theodore J.
    JOURNAL OF IMMUNOLOGY, 2007, 179 (06): : 3937 - 3946
  • [29] TLR9 contributes to antiviral immunity during gammaherpesvirus infection
    Guggemoos, Simone
    Hangel, Doris
    Hamm, Svetlana
    Heit, Antje
    Bauer, Stefan
    Adler, Heiko
    JOURNAL OF IMMUNOLOGY, 2008, 180 (01): : 438 - 443
  • [30] A TLR9 agonist enhances the anti-tumor immunity of peptide and lipopeptide vaccines via different mechanisms
    Ying-Chyi Song
    Shih-Jen Liu
    Scientific Reports, 5
12345